BUSA I, ORDONEZ-MENA JM, YANG Y, WOLSTENHOLME J, PETROU S, TAYLOR CJ, O'CALLAGHAN CA, FRASER SDS, TAAL MW, MCMANUS RJ, HIRST JA and HOBBS FDR, 2022. Quality of life in older adults with chronic kidney disease and transient changes in renal function: Findings from the Oxford Renal cohort PLoS One. 17(10), e0275572 GALLAGHER H, DUMBLETON J, MAISHMAN T, WHITEHEAD A, MOORE MV, FUAT A, FITZMAURICE D, HENDERSON RA, LORD J, GRIFFITH KE, STEVENS P, TAAL MW, STEVENSON D, FRASER SD, LOWN M, HAWKEY CJ and RODERICK PJ, 2022. Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease Trials. 23(1), 331 NAKAFERO G, GRAINGE MJ, CARD T, MALLEN CD, RILEY R, VAN DER WINDT D, FOX CP, TAAL MW, AITHAL GP, WILLIAMS HC and ABISHEK A, 2022. Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink Aurum Rheumatol Adv Pract. 6(2), rkac046 BUCHANAN C, MAHMOUD H, COX E, NOBLE R, PRESTWICH B, KASMI I, TAAL MW, FRANCIS S and SELBY NM, 2021. Multiparametric MRI assessment of renal structure and function in Acute Kidney Injury and renal recovery Clin Kidney J. sfaa221 BUCHANAN CE, MAHMOUD H, COX EF, MCCULLOCH T, PRESTWICH BL, TAAL MW, SELBY NM and FRANCIS ST, 2020. Quantitative assessment of renal structural and functional changes in chronic kidney disease using multi-parametric magnetic resonance imaging. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association: 35(6):955-964. 35(6), pii: gfz129 VIRAMONTES HÖRNER D, WILLINGHAM FC, SELBY NM and TAAL MW, 2020. Impact of Dietetic Intervention on Skin Autofluorescence and Nutritional Status in Persons Receiving Dialysis: A Proof of Principle Study. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. (In Press.)
VIRAMONTES HÖRNER D, SELBY NM and TAAL MW, 2020. Skin autofluorescence and malnutrition as predictors of mortality in persons receiving dialysis: a prospective cohort study. Journal of human nutrition and dietetics : the official journal of the British Dietetic Association. 33(6), 852-861 JONES R, BARRETT J, BRETTELL E, COCKWELL P, DALTON RN, DEEKS J, EAGLESTONE G, PELLATT-HIGGINS T, KALRA PA, KHUNTI K, MORRIS F, OTTRIDGE R, SITCH A, STEVENS PE, SHARPE C, SUTTON A, TAAL M and LAMB EJ, 2020. Biological Variation of Cardiac Troponins in Chronic Kidney Disease Ann Clin Biochem. 57(2), 162-169 FRASER SDS, BARKER J, RODERICK PJ, YUEN HM, SHARDLOW A, MORRIS JE, MCINTYRE NJ, FLUCK RJ, MCINTYRE CW and TAAL MW, 2020. Health-related quality of life, functional impairment and comorbidity in people with mild-to-moderate chronic kidney disease: a cross-sectional study BMJ Open. 10(8), E040286 SIMON DS and TAAL MW, 2020. Helping people to live well with chronic kidney disease Br J Hosp Med (Lond). 81(6), 1-10 GREENWOOD SA, KOUFAKI P, MACDONALD J, BHANDARI S, BURTON J, DASGUPTA I, FARRINGTON K, FORD I, KALRA PA, KEAN S, KUMWENDA M, MACDOUGALL IC, MESSOW C-M, MITRA S, REID C, SMITH AC, TAAL MW and ET AL, 2020. The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trial Clinical Kidney Journal. NIXON AC, WILKINSON TJ, YOUNG HML, TAAL MW, PENDLETON N, MITRA S, BRADY ME, DHAYGUDE AP and SMITH AC, 2020. Symptom-burden in people living with frailty and chronic kidney disease BMC Nephrol: 21(1):411. 21(1), 411 KOLHE NV, FLUCK RJ, SELBY NM and TAAL MW, 2020. Acute Kidney Injury associated with COVID-19: A retrospective cohort study PLoS Med. 17(10), e1003406 DUKKA H, KALRA PA, WILKIE M, BHANDARI S, DAVIES SJ, BARRATT J, SQUIRE I, ODUDU A, SELBY NM, MCINTYRE C, ROBERTSON F and TAAL MW, 2019. Peritoneal Ultrafiltration for Heart Failure: Lessons from a Randomized Controlled Trial. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 39(5), 486-489 VIRAMONTES HÖRNER D and TAAL MW, 2019. Skin autofluorescence: an emerging biomarker in persons with kidney disease. Current opinion in nephrology and hypertension. 28(6), 507-512 DELANAYE P, JAGER KJ, BÖKENKAMP A, CHRISTENSSON A, DUBOURG L, ERIKSEN BO, GAILLARD F, GAMBARO G, VAN DER GIET M, GLASSOCK RJ, INDRIDASON OS, VAN LONDEN M, MARIAT C, MELSOM T, MORANNE O, NORDIN G, PALSSON R, POTTEL H, RULE AD, SCHAEFFNER E, TAAL MW, WHITE C, GRUBB A and VAN DEN BRAND JAJG, 2019. CKD: A Call for an Age-Adapted Definition J Am Soc Nephrol. 30(10), 1785-1805 KENNEDY OJ, PIRASTU N, POOLE R, FALLOWFIELD JA, HAYES PC, GRZESZKOWIAK EJ, TAAL MW, WILSON JF, PARKES J and RODERICK PJ, 2019. Coffee consumption and kidney function: a Mendelian randomisation study Am J Kidney Dis. 75(5), 753-761 MCINTYRE NJ, SHARDLOW A, FLUCK RJ, MCINTYRE CW and TAAL MW, 2019. Determinants of change in
Arterial Stiffness over 5 years in Early Chronic Kidney Disease Nephrology, Dialysis and Transplantation. gfz170 SELBY NM, BLANKESTIJN PJ, BOOR P, COMBE C, ECKARDT KU, EIKEFJORD E, GARCIA-FERNANDEZ N, GOLAY X, GORDON I, GRENIER N, HOCKINGS PD, JENSEN JD, JOLES JA, KALRA PA, KRÄMER BK, MARK PB, MENDICHOVSZKY IA, NIKOLIC O, ODUDU A, ONG ACM, ORTIZ A, PRUIJM M, REMUZZI G, RØRVIK J, DE SEIGNEUX S, SIMMS RJ, SLATINSKA J, SUMMERS P, TAAL MW, THOENY HC, VALLÉE JP, WOLF M, CAROLI A and SOURBRON S, 2018. Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 33(suppl_2), ii4-ii14 FRANCIS S, BUCHANAN CE, PRESTWICH B and TAAL MW, 2017. Sodium MRI: a new frontier in imaging in nephrology. Current opinion in nephrology and hypertension. 26(6), 435-441 COX, E.F., BUCHANAN, C.E., BRADLEY, C.R., PRESTWICH, B., MAHMOUD, H., TAAL, M., SELBY, N.M. and FRANCIS, S.T., 2017. Multiparametric Renal Magnetic Resonance Imaging: validation, interventions and alterations in Chronic Kidney Disease Frontiers in Physiology. 8(696), TEASDALE EJ, LEYDON G, FRASER S, RODERICK P and TAAL MW, 2017. Patients' Experiences After CKD Diagnosis: A Meta-ethnographic Study and Systematic Review Am J Kidney Dis. 70(5), 656-665 KOLHE, N. V., REILLY, T., LEUNG, J., FLUCK, R. J., SWINSCOE, K. E., SELBY, N. M. and TAAL, M. W., 2016. A simple care bundle for use in acute kidney injury: a propensity score matched cohort study: Nephrol Dial Transplant Nephrol Dial Transplant. 31(11), 1846-1854 FRASER SD, RODERICK PJ and TAAL MW, 2016. Where now for proteinuria testing in chronic kidney disease?: Good evidence can clarify a potentially confusing message. The British journal of general practice : the journal of the Royal College of General Practitioners. 66(645), 215-7 BUCHANAN C, MOHAMMED A, COX E, KOHLER K, CANAUD B, TAAL MW, SELBY NM, FRANCIS ST and MCINTYRE CW, 2016. Intradialytic cardiac MRI to assess cardiovascular responses in a short term randomised controlled trial of haemodiafiltration and haemodialysis Journal of American Society of Nephrology. epub Nov 2016, KOLHE NV, REILLY T, LEUNG J, FLUCK RJ, SWINSCOE KE and SELBY NM, 2016. A simple care bundle for use in acute kidney injury: a propensity score matched cohort study Nephrol Dial Transplant. 31(11), 1846-1854 FARRINGTON K, COVIC A, AUCELLA F, CLYNE N, DE VOS L, FINDLAY A, FOUQUE D, GRODZICKI T, IYASERE O, JAGER KJ, JOOSTEN H, MACIAS JF, MOONEY A, NITSCH D, STRYCKERS M, TAAL M, TATTERSALL J, VAN ASSELT D, VAN DEN NOORTGATE N, NISTOR I and VAN BIESEN W, 2016. Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45mL/min/1.73m2): ERBP Guideline Development Group Nephrol Dial Transplant. 31(Suppl 2), ii1-ii66
KOLHE, NV, MUIRHEAD, A, WILKES, SR, FLUCK, RJ and TAAL, MW, 2015. National trends in acute kidney injuring requiring dialysis in England between 1998 and 2013: a retrospective analysis of Hospital Episode Statistics Kidney International. 88, 1161–1169 KOLHE, N. V., STAPLES, D., REILLY, T., MERRISON, D., MCINTYRE, C. W., FLUCK, R. J., SELBY, N. M. and TAAL, M. W., 2015. Impact of Compliance with a Care Bundle on Acute Kidney Injury Outcomes: A Prospective Observational Study: PLoS One PLoS One. 10(7), e0132279 HORNE, K. L., SHARDLOW, A., TAAL, M. W. and SELBY, N. M., 2015. Long Term Outcomes after Acute Kidney Injury: Lessons from the ARID Study: Nephron Nephron. 131(2), 102-6 FRASER SD, RODERICK PJ, MAY CR, MCINTYRE N, MCINTYRE C, FLUCK RJ, SHARDLOW A and TAAL MW, 2015. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC nephrology. 16, 193 HILL NR, LASSERSON D, THOMPSON B, PERERA-SALAZAR R, WOLSTENHOLME J, BOWER P, BLAKEMAN T, FITZMAURICE D, LITTLE P, FEDER G, QURESHI N, TAAL M, TOWNEND J, FERRO C, MCMANUS R and HOBBS FR, 2014. Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial. Trials. 15(1), 160 FRASER SDS, RODERICK PJ, MCINTYRE NJ, HARRIS S, MCINTYRE CW, FLUCK RJ and TAAL MW, 2014. Skin Autofluorescence and All-Cause Mortality in Stage 3 CKD. Clinical journal of the American Society of Nephrology : CJASN. (In Press.)
NERBASS FB, PECOITS-FILHO R, MCINTYRE NJ, MCINTYRE CW, WILLINGHAM FC and TAAL MW, 2014. Demographic Associations of High Estimated Sodium Intake and Frequency of Consumption of High-Sodium Foods in People With Chronic Kidney Disease Stage 3 in England. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. (In Press.)
LAMB EJ, BRETTELL EA, COCKWELL P, DALTON N, DEEKS JJ, HARRIS K, HIGGINS T, KALRA PA, KHUNTI K, LOUD F, OTTRIDGE RS, SHARPE CC, SITCH AJ, STEVENS PE, SUTTON AJ, TAAL MW and EGFR-C STUDY GROUP, 2014. The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease--prospective longitudinal study in a multiethnic population. BMC nephrology. 15(1), 13 TAAL MW, 2014. Arterial stiffness in chronic kidney disease: an update. Current opinion in nephrology and hypertension. 23(2), 169-73 NERBASS FB, PECOITS-FILHO R, MCINTYRE NJ, MCINTYRE CW and TAAL MW, 2014. High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients. European journal of clinical nutrition. 69(7), 786-90 MCINTYRE NJ, FLUCK RJ, MCINTYRE CW, FAKIS A and TAAL MW, 2013. Determinants of arterial stiffness in chronic kidney disease stage 3. PloS one. 8(1), e55444 CROWLEY LE, JOHNSON CP, MCINTYRE N, FLUCK RJ, MCINTYRE CW, TAAL MW and LEUNG JCH, 2013. Tissue advanced glycation end product deposition after kidney transplantation. Nephron. Clinical practice. 124(1-2), 54-9 FRASER SDS, RODERICK PJ, CASEY M, TAAL MW, YUEN HM and NUTBEAM D, 2013. Prevalence and associations of limited health literacy in chronic kidney disease: a systematic review. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 28(1), 129-37 ALASHEK WA, MCINTYRE CW and TAAL MW, 2012. Determinants of survival in patients receiving dialysis in Libya. Hemodialysis international. International Symposium on Home Hemodialysis. (In Press.)
ALASHEK WA, MCINTYRE CW and TAAL MW, 2012. Vascular access in patients receiving hemodialysis in Libya. The journal of vascular access. 13(4), 468-74 FRASER SDS, RODERICK PJ, MCINTYRE NJ, HARRIS S, MCINTYRE CW, FLUCK RJ and TAAL MW, 2012. Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3. Nephron. Clinical practice. 122(1-2), 58-65 TAAL MW, 2012. Chronic kidney disease 10 years on: what have we learned? Current opinion in nephrology and hypertension. 21(6), 607-11 MCINTYRE NJ, FLUCK R, MCINTYRE C and TAAL M, 2012. Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease. The British journal of general practice : the journal of the Royal College of General Practitioners. 62(597), e227-32 ODUDU, AGHOGHO, LAMBIE, STEWART, TAAL, MAARTEN W, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, 2011. Use of Online Conductivity Monitoring to Study Sodium Mass Balance in Chronic Haemodialysis Patients: Prospects for Treatment Individualisation. Kidney & blood pressure research. 34(6), 439-446 MCINTYRE, N.J., FLUCK, R.J., MCINTYRE, C.W. and TAAL, M.W., 2011. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3 Clinical Journal of the American Society of Nephrology. 6(10), 2356-2363 ALASHEK WA, MCINTYRE CW and TAAL MW, 2011. Provision And Quality Of Dialysis Services In Libya. Hemodialysis International. International Symposium On Home Hemodialysis. 15(4), 444-52 MCINTYRE NJ, FLUCK RJ, MCINTYRE CW and TAAL MW, 2011. Risk Profile In Chronic Kidney Disease Stage 3: Older Versus Younger Patients. Nephron. Clinical Practice. 119(4), c269-76 MCINTYRE NJ, FLUCK RJ, MCINTYRE CW and TAAL MW, 2011. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clinical journal of the American Society of Nephrology : CJASN. 6(10), 2356-63 TAAL MW, 2011. Predicting renal risk in the general population: do we have the right formula? Clinical journal of the American Society of Nephrology : CJASN. 6(7), 1523-5 MACTIER R, DAVIES S, DUDLEY C, HARDEN P, JONES C, KANAGASUNDARAM S, LEWINGTON A, RICHARDSON D, TAAL M, ANDREWS P, BAKER R, BREEN C, DUNCAN N, FARRINGTON K, FLUCK R, GEDDES C, GOLDSMITH D, HOENICH N, HOLT S, JARDINE A, JENKINS S, KUMWENDA M, LINDLEY E, MACGREGOR M, MIKHAIL A, SHARPLES E, SHRESTHA B, SHRIVASTAVA R, STEDDON S, WARWICK G, WILKIE M, WOODROW G and WRIGHT M, 2011. Summary of the 5th edition of the Renal Association Clinical Practice Guidelines (2009-2012). Nephron. Clinical practice. 118 Suppl 1, c27-70 MCINTYRE, NATASHA J, CHESTERTON, LINDSAY J, JOHN, STEPHEN G, JEFFERIES, HELEN J, BURTON, JAMES O, TAAL, MAARTEN W, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, 2010. Tissue-advanced glycation end product concentration in dialysis patients. Clinical journal of the American Society of Nephrology : CJASN. 5(1), 51-5 JAFFER, YASMIN, SELBY, NICHOLAS M, TAAL, MAARTEN W, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, 2008. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. American journal of kidney diseases : the official journal of the National Kidney Foundation. 51(2), 233-41 MCINTYRE NJ and TAAL MW, 2008. How to measure proteinuria? Current opinion in nephrology and hypertension. 17(6), 600-3 TAAL MW and BRENNER BM, 2008. Renal risk scores: progress and prospects. Kidney international. 73(11), 1216-9 TAAL, MAARTEN W, SIGRIST, MHAIRI K, FAKIS, APOSTOLOS, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, 2007. Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5. Nephron. Clinical practice. 107(4), c177-81 TAAL MW and BRENNER BM, 2007. Defining renal risk. Current opinion in nephrology and hypertension. 16(6), 554-6 SIGRIST, M., BUNGAY, P., TAAL, M.W. and MCINTYRE, C.W., 2006. Vascular calcification and cardiovascular function in chronic kidney disease Nephrology, Dialysis, Transplantation. 21(3), 707-714 TAAL, MAARTEN W, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, 2006. Preventing catheter related infections in haemodialysis patients. Current Opinion in Nephrology and Hypertension. 15(6), 599-602 CHESTERTON, LINDSAY J, PRIESTMAN, WILLIAM S, LAMBIE, STEWART H, FIELDING, CATHERINE A, TAAL, MAARTEN W, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, 2006. Continuous online monitoring of ionic dialysance allows modification of delivered hemodialysis treatment time. Hemodialysis international. International Symposium on Home Hemodialysis. 10(4), 346-50
SELBY, NICHOLAS M, FONSECA, SALLY, HULME, LISA, FLUCK, RICHARD J, TAAL, MAARTEN W and MCINTYRE, CHRISTOPHER W, 2005. Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin. Nephrology, Dialysis, Transplantation. 20(9), 1848-53 CHESTERTON, LINDSAY J, SIGRIST, MHAIRI K, BENNETT, TERENCE, TAAL, MAARTEN W and MCINTYRE, CHRISTOPHER W, 2005. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrology, Dialysis, Transplantation. 20(6), 1140-7 PRIESTMAN, WILLIAM S, DENUNZIO, MARIO, TAAL, MAARTEN W, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, 2005. An unusual case of renovascular hypertension-renal artery stenosis of a pelvic kidney with aberrant blood supply. Nephrology, Dialysis, Transplantation. 20(12), 2861-3 SIGRIST, MHAIRI K, DEVLIN, LISA, TAAL, MAARTEN W, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, 2005. Length of interdialytic interval influences serum calcium and phosphorus concentrations. Nephrology, Dialysis, Transplantation. 20(8), 1643-6 CHESTERTON, LINDSAY, LAMBIE, STEWART H, HULME, LISA J, TAAL, MAARTEN, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, 2005. Online measurement of haemoglobin concentration. Nephrology, Dialysis, Transplantation. 20(9), 1951-5 LAMBIE, STEWART H, HULME, LISA J, TAAL, MAARTEN, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, 2005. Prospective study of gentamicin locking of tunnelled dialysis catheters: the effect on infection rates and CRP. Kidney International. 67(1), 378 MCINTYRE, CHRISTOPHER W, HULME, LISA J, TAAL, MAARTEN and FLUCK, RICHARD J, 2004. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney International. 66(2), 801-5 TAAL, MAARTEN W, CHESTERTON, LINDSAY J and MCINTYRE, CHRISTOPHER W, 2004. Venography at insertion of tunnelled internal jugular vein dialysis catheters reveals significant occult stenosis. Nephrology, Dialysis, Transplantation. 19(6), 1542-5 MCINTYRE, CHRISTOPHER W and TAAL, MAARTEN W, 2004. Imaging and assessment of vascular calcification in chronic kidney disease patients. Current Opinion in Nephrology and Hypertension. 13(6), 637-40 LAMBIE, STEWART H, TAAL, MAARTEN W, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, 2004. Analysis of factors associated with variability in haemodialysis adequacy. Nephrology, Dialysis, Transplantation. 19(2), 406-12 MCINTYRE, CHRISTOPHER W, LAMBIE, STEWART H, TAAL, MAARTEN W and FLUCK, RICHARD J, 2003. Assessment of haemodialysis adequacy by ionic dialysance: intra-patient variability of delivered treatment. Nephrology, Dialysis, Transplantation. 18(3), 559-63 MCINTYRE, CHRISTOPHER W, TAAL, MAARTEN W, FLUCK, RICHARD J and HINWOOD, DAVID, 2003. Adherence of tunnelled haemodialysis catheter to superior vena caval stent: successful percutaneous removal. Nephrology, Dialysis, Transplantation. 18(2), 432-3 TAAL MW, 2003. Proteinuria: new information from an old friend. Current opinion in nephrology and hypertension. 12(6), 615-7 TAAL MW, ROE S, MASUD T, GREEN D, PORTER C and CASSIDY MJD, 2003. Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney international. 63(3), 1116-20 WILHELM MJ, PRATSCHKE J, BEATO F, TAAL M, LASKOWSKI IA, PAZ DM, SCHMID C, HANCOCK WW, SCHELD HH and TILNEY NL, 2002. Activation of proinflammatory mediators in heart transplants from brain-dead donors: evidence from a model of chronic rat cardiac allograft rejection. Transplantation proceedings. 34(6), 2359-60 TAAL MW and BRENNER BM, 2002. Combination ACEI and ARB therapy: additional benefit in renoprotection? Current opinion in nephrology and hypertension. 11(4), 377-81 LASKOWSKI IA, PRATSCHKE J, WILHELM MJ, DONG VM, BEATO F, TAAL M, GASSER M, HANCOCK WW, SAYEGH MH and TILNEY NL, 2002. Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. Journal of the American Society of Nephrology : JASN. 13(2), 519-27
TAAL MW and BRENNER BM, 2001. Achieving maximal renal protection in nondiabetic chronic renal disease. American journal of kidney diseases : the official journal of the National Kidney Foundation. 38(6), 1365-71 TAAL MW, NENOV VD, WONG W, SATYAL SR, SAKHAROVA O, CHOI JH, TROY JL and BRENNER BM, 2001. Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone. Journal of the American Society of Nephrology : JASN. 12(10), 2051-9
TAAL MW and BRENNER BM, 2001. Evolving strategies for renoprotection: non-diabetic chronic renal disease. Current opinion in nephrology and hypertension. 10(4), 523-31 TAAL MW and VAN ZYL-SMIT R, 2001. Cost-effectiveness of hepatitis B vaccination in haemodialysis patients. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 91(4), 340-4
TAAL MW, CHERTOW GM, RENNKE HG, GURNANI A, JIANG T, SHAHSAFAEI A, TROY JL, BRENNER BM and MACKENZIE HS, 2001. Mechanisms underlying renoprotection during renin-angiotensin system blockade. American journal of physiology. Renal physiology. 280(2), F343-55
WILHELM MJ, PRATSCHKE J, BEATO F, TAAL M, KUSAKA M, HANCOCK WW and TILNEY NL, 2000. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation. 102(19), 2426-33
TAAL MW, ZANDI-NEJAD K, WEENING B, SHAHSAFAEI A, KATO S, LEE KW, ZIAI F, JIANG T, BRENNER BM and MACKENZIE HS, 2000. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney international. 58(4), 1664-76 TAAL MW, OMER SA, NADIM MK and MACKENZIE HS, 2000. Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression. Current opinion in nephrology and hypertension. 9(4), 323-31 TAAL MW and VAN ZYL-SMIT R, 2000. Hepatitis C virus infection in chronic haemodialysis patients--relationship to blood transfusions and dialyser re-use. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 90(6), 621-5
NENOV VD, TAAL MW, SAKHAROVA OV and BRENNER BM, 2000. Multi-hit nature of chronic renal disease. Current opinion in nephrology and hypertension. 9(2), 85-97 MCMAHON R, MURPHY M, CLARKSON M, TAAL M, MACKENZIE HS, GODSON C, MARTIN F and BRADY HR, 2000. IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1. The Journal of biological chemistry. 275(14), 9901-4 TAAL MW, MASUD T, GREEN D and CASSIDY MJ, 1999. Risk factors for reduced bone density in haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 14(8), 1922-8
TAAL MW, CASSIDY MJ, PEARSON D, GREEN D and MASUD T, 1999. Usefulness of quantitative heel ultrasound compared with dual-energy X-ray absorptiometry in determining bone mineral density in chronic haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 14(8), 1917-21
MACKENZIE HS, ZIAI F, OMER SA, NADIM MK and TAAL MW, 1999. Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future. Journal of the American Society of Nephrology : JASN. 10 Suppl 12, S283-6
TAAL MW and BRENNER BM, 1999. ACE-I vs angiotensin II receptor antagonists: prevention of renal injury in chronic rat models. Journal of human hypertension. 13 Suppl 1, S51-6; discussion S61 SELBY NM, FONSECA SA, FLUCK RJ and TAAL MW, 1. Hemoglobin variability with epoetin beta and continuous erythropoietin receptor activator in patients on peritoneal dialysis. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 32(2), 177-82 SELBY, NICHOLAS M, FONSECA, SALLY, HULME, LISA, FLUCK, RICHARD J, TAAL, MAARTEN W and MCINTYRE, CHRISTOPHER W, Automated peritoneal dialysis has significant effects on systemic hemodynamics. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 26(3), 328-35
LAMBIE, STEWART H, TAAL, MAARTEN W, FLUCK, RICHARD J and MCINTYRE, CHRISTOPHER W, Online conductivity monitoring: validation and usefulness in a clinical trial of reduced dialysate conductivity. ASAIO journal (American Society for Artificial Internal Organs : 1992). 51(1), 70-6
SELBY, NICHOLAS M, TAAL, MAARTEN W and MCINTYRE, CHRISTOPHER W, Comparison of progressive conductivity reduction with diacontrol and standard dialysis. ASAIO journal (American Society for Artificial Internal Organs : 1992). 53(2), 194-200
SELBY, NICHOLAS M, FLUCK, RICHARD J, TAAL, MAARTEN W and MCINTYRE, CHRISTOPHER W, Effects of acetate-free double-chamber hemodiafiltration and standard dialysis on systemic hemodynamics and troponin T levels. ASAIO journal (American Society for Artificial Internal Organs : 1992). 52(1), 62-9
WILLINGHAM FC, SPEELMAN I, HAMILTON J, VON FRAGSTEIN G, SHAW S and TAAL MW, Feasibility and effectiveness of pre-emptive rehabilitation in persons approaching dialysis (PREHAB). J of Ren Care. (In Press.)